Clinical trials in Ukraine – a first hand perspective

By Oximio

Damage to infrastructure, supply chain disruption, patient and researcher safety – conflict in Ukraine has forced clinical trial organisers to adapt quickly. Thanks to their ingenuity, and the resilience of their Ukrainian partners, the country’s clinical trial map is getting back on track. Through new partnerships with labs in neighbouring countries, flexibility for rules on treatments and new road routes for importing and exporting materials, the freeze on research thawed virtually overnight. In this webinar, Oximio – who have handled thousands of shipments for dozens of sponsors over the course of the conflict – analyse the legal and logistical transformation. Led by first-hand expertise from the company’s Ukraine team, they explain the key factors in enabling clinical trials to start and resume. Fill in your details to find out more.

Enter your details below to view the free Whitepaper

By downloading this case study, you acknowledge that GlobalData may share your information with Oximio and that your personal data will be used as described in their Privacy Policy

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.